Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3638271

N#Cc1cc(Oc2c(Cl)ccc(CNC(=O)c3[nH]c(N)nc3Cl)c2F)cc(C(F)F)c1.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.38
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
PTGES O14684 1/20 0.33
EPHX2 P34913 1/20 0.32
RORC P51449 1/20 0.32
F3 P13726 1/20 0.31
EGLN2 Q96KS0 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3032295 0.96 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19PTGESEPHX2
Trifluoroacetic Acid SCHEMBL3017399 0.91 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19PTGESEPHX2
Trifluoroacetic Acid SCHEMBL3022995 0.91 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19PTGESEPHX2
Trifluoroacetic Acid SCHEMBL13560564 0.91 CYP3A4 (0.40) CYP3A4CYP2C9CYP2C19PTGESEPHX2
Trifluoroacetic Acid SCHEMBL3025136 0.89 CYP3A4 (0.39) CYP3A4CYP2C9CYP2C19PTGESEPHX2
Trifluoroacetic Acid SCHEMBL13560570 0.88 CYP3A4 (0.35) CYP3A4CYP2C9CYP2C19PTGESEPHX2
Trifluoroacetic Acid SCHEMBL3036142 0.87 CYP3A4 (0.37) CYP3A4CYP2C9CYP2C19PTGESEPHX2
SCHEMBL3023315 0.87 CYP3A4 (0.43) CYP3A4CYP2C9CYP2C19PTGESEPHX2
SCHEMBL3027058 0.86 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19PTGESEPHX2
SCHEMBL3029925 0.86 CYP3A4 (0.43) CYP3A4CYP2C9CYP2C19PTGESEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 EP disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO disclosed